Skip to content

Serological Study of the Exposure of Personnel to COVID-19

Serological Study of the Exposure of Personnel to Sars-cov-2 in an Urban Hospital Two Months After Managing an Influx of COVID Patients 19

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04422977
Acronym
SEROPHUGAC
Enrollment
957
Registered
2020-06-09
Start date
2020-06-08
Completion date
2020-07-10
Last updated
2024-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sars-CoV2

Brief summary

A seroconversion test for SARS-Cov-2 will be offered to all the employees of a care institution, which has treated 240 patients hospitalized for COVID disease between 28/02 and 30/04/2020. The seroconversion test will be with a questionnaire to determine: * whether the subject has shown signs of infection in the last 3 recent months * if the subject has been in contact with COVID-diagnosed subjects (RT-PCR diagnosis or scanner) outside of the activity or within the professional activity (patient or colleague) * Working conditions during the period * The level of knowledge and respect of the barrier measures practices. * Respect for distance during meals professional. Overall seroprevalence and stratified seroprevalence by care and administrative areas will be determined.

Interventions

DIAGNOSTIC_TESTSars-Cov-2 serology

Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff

Sponsors

Centre Hospitalier Saint Joseph Saint Luc de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject who worked at Saint Joseph Saint Luke's Hospital during the epidemic wave (male or female). * Free and informed consent * Social security affiliation

Exclusion criteria

* Subject refusal * Subject on leave during the entire period

Design outcomes

Primary

MeasureTime frameDescription
Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff with a seroconversion test for SARS-Cov-21 monthMeasurement of overall seroprevalence of SARS-Cov-2 in an hospital staff

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026